Efficacy and safety of brexpiprazole for the treatment of acute schizophrenia in Japan: A 6 ‐week, randomized, double‐blind, placebo‐controlled study

Psychiatry and Clinical Neurosciences,Volume 0, Issue ja, -Not available-.

Source: Psychiatry and Clinical Neurosciences - May 18, 2018 Category: Neuroscience Authors: Jun Ishigooka MD, PhD , Shuichi Iwashita MSc , Yoshihiro Tadori PhD Source Type: research